Similar articles

• The systemic and coronary hemodynamic effects of lidoflazine.

  Thomsen JH, Stenlund RR, Corliss RJ, Sialer S, Rowe GG. Thomsen JH, et al. Arch Int Pharmacodyn Ther. 1968 Mar;172(1):15-23. Arch Int Pharmacodyn Ther. 1968. PMID: 5650324 No abstract available.
• Comparative profile of L 3428 and other antianginal agents on cardiac hemodynamics.

  Petta JM, Zaccheo VJ. Petta JM, et al. J Pharmacol Exp Ther. 1971 Feb;176(2):328-38. J Pharmacol Exp Ther. 1971. PMID: 4998691 No abstract available.
• Changes in hemodynamic parameters, inotropic state, and myocardial oxygen consumption owing to intravenous application of nitroglycerin.

  Hempelmann G, Piepenbrock S, Seitz W, Karliczek G. Hempelmann G, et al. J Thorac Cardiovasc Surg. 1977 Jun;73(6):836-47. J Thorac Cardiovasc Surg. 1977. PMID: 404479
• Cardiac dysfunction in the perioperative period: pathophysiology, diagnosis, and treatment.

  Lappas DG, Powell WM Jr, Daggett WM. Lappas DG, et al. Anesthesiology. 1977 Aug;47(2):117-37. doi: 10.1097/00000542-197708000-00004. Anesthesiology. 1977. PMID: 406809 Review. No abstract available.
• [Coronary heart disease and its differential treatment].

  Diewitz M. Diewitz M. Med Welt. 1975 Oct 24;26(43):1980-8. Med Welt. 1975. PMID: 583 Review. German. No abstract available.